Free Trial

Janus Henderson Group PLC Has $35.80 Million Position in Bath & Body Works, Inc. (NYSE:BBWI)

Bath & Body Works logo with Retail/Wholesale background

Janus Henderson Group PLC increased its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 99.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,121,520 shares of the company's stock after buying an additional 559,851 shares during the period. Janus Henderson Group PLC owned 0.51% of Bath & Body Works worth $35,799,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Anthracite Investment Company Inc. acquired a new stake in shares of Bath & Body Works in the third quarter worth about $2,921,000. Forest Avenue Capital Management LP raised its stake in shares of Bath & Body Works by 19.1% in the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company's stock valued at $46,851,000 after acquiring an additional 235,173 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Bath & Body Works by 328.7% in the 3rd quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company's stock worth $34,153,000 after purchasing an additional 820,379 shares during the last quarter. New York State Teachers Retirement System boosted its position in Bath & Body Works by 18.1% during the third quarter. New York State Teachers Retirement System now owns 266,235 shares of the company's stock worth $8,498,000 after purchasing an additional 40,793 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Bath & Body Works during the third quarter valued at approximately $1,472,000. Institutional investors and hedge funds own 95.14% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on BBWI. Evercore ISI decreased their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating for the company in a report on Wednesday, August 28th. Raymond James decreased their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an "outperform" rating for the company in a report on Thursday, August 29th. Piper Sandler lifted their price objective on Bath & Body Works from $35.00 to $36.00 and gave the stock a "neutral" rating in a research note on Tuesday, November 26th. Telsey Advisory Group restated an "outperform" rating and set a $42.00 target price on shares of Bath & Body Works in a research note on Monday, November 25th. Finally, Robert W. Baird lowered their target price on Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating on the stock in a report on Thursday, August 29th. One analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of "Moderate Buy" and a consensus price target of $41.88.

View Our Latest Report on Bath & Body Works

Bath & Body Works Stock Down 0.5 %

Bath & Body Works stock traded down $0.18 on Friday, hitting $36.60. The company's stock had a trading volume of 5,624,271 shares, compared to its average volume of 6,509,393. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99. The firm has a market cap of $7.93 billion, a P/E ratio of 8.93, a price-to-earnings-growth ratio of 1.43 and a beta of 1.83. The company has a fifty day moving average price of $31.81 and a 200-day moving average price of $35.14.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm's revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.48 earnings per share. Analysts anticipate that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.19%. Bath & Body Works's dividend payout ratio (DPR) is presently 19.51%.

Insider Activity at Bath & Body Works

In other news, CEO Gina Boswell purchased 6,000 shares of the business's stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares of the company's stock, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.27% of the stock is owned by insiders.

Bath & Body Works Company Profile

(Free Report)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Further Reading

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in Bath & Body Works right now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines